1700011A15Rik activators comprise a versatile array of chemical compounds that enhance the functional activity of this specific protein through various indirect mechanisms. For instance, Forskolin, a well-known adenylyl cyclase activator, catalyzes the conversion of ATP to cAMP, which subsequently activates PKA. Activated PKA has a wide range of protein substrates, including phosphorylation sites on 1700011A15Rik, which could enhance its activity within the cell. Epigallocatechin gallate, a polyphenol found in green tea, acts as a kinase inhibitor, potentially reducing kinase-mediated inhibition on 1700011A15Rik, thereby enhancing its functional role in the cell. Similarly, lipid signaling is modulated by Sphingosine-1-phosphate, which may amplify lipid-related functions of 1700011A15Rik, while Thapsigargin and A23187, by disrupting calcium homeostasis, could conceivably activate calcium-dependent processes that involve 1700011A15Rik. PMA acts as a PKC activator, thereby potentially initiating signaling cascades that enhance the activity of 1700011A15Rik via protein kinase C-related pathways.
1700011A15Rik activators encompass a diverse array of chemical compounds that indirectly promote the functional activity of1700011A15Rik through various cellular signaling pathways. Forskolin, a direct activator of adenylyl cyclase, increases intracellular cAMP levels, which then stimulates protein kinase A (PKA). PKA can phosphorylate a range of substrates that potentially interact with or regulate 1700011A15Rik, thereby enhancing its activity. Analogous to forskolin, Dibutyryl cAMP, a cAMP analog, exerts its effects via activation of PKA, which may lead to phosphorylation and subsequent activation of proteins that modulate 1700011A15Rik's activity. IBMX, which inhibits phosphodiesterases and thus prevents cAMP and cGMP degradation, results in the activation of PKA or PKG. The activation of these kinases could promote phosphorylation events that indirectly increase 1700011A15Rik activity. Epigallocatechin gallate, a polyphenolic compound, may inhibit a range of kinases, potentially lifting repression off pathways that enhance 1700011A15Rik's functional role.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
As a kinase inhibitor, epigallocatechin gallate may reduce competitive kinase activity, indirectly enhancing 1700011A15Rik function. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Engages in lipid signaling modulation, which could enhance the lipid-related functions of 1700011A15Rik if involved. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase, increasing intracellular calcium and potentially enhancing 1700011A15Rik activity if calcium-dependent. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a PKC activator, PMA modulates signaling pathways that could increase the functional activity of 1700011A15Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, LY294002 may indirectly enhance the activity of 1700011A15Rik by altering PI3K/Akt signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, Wortmannin, could indirectly increase 1700011A15Rik activity through the PI3K/Akt pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, SB203580, may shift signaling in a manner that indirectly enhances 1700011A15Rik function. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
By increasing intracellular calcium levels, A23187 could activate calcium-dependent pathways involving 1700011A15Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein could indirectly enhance the activity of 1700011A15Rik by affecting related signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Though a broad-spectrum kinase inhibitor, Staurosporine may selectively activate 1700011A15Rik-related pathways by inhibiting specific kinases that suppress it. | ||||||